TETRAPHASE PHARMACEUTICALS INC: cashflow_financing

Value{"amount": 118268000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2013-01-01 – 2013-12-31
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-14-086844 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:17.864451+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/cashflow-financing/2013-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bae450b0-6a61-41c7-8f8a-d0e2d873bc2e

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies